Funding Archives

News and Trends 2 Sep 2022

Abivax pulls in €49.2M but needs more to complete ulcerative colitis program

French biotech company Abivax has completed an oversubscribed €49.2 million ($49 million) financing round. This included U.S. and European biotech specialist investors, led by TCGX, with participation from Venrock Healthcare Capital Partners, Deep Track Capital, Sofinnova Partners, Invus, and Truffle Capital through the completion of two transactions. The first was a reserved capital increase of […]

September 2, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 2 Sep 2022

Neukio Biotherapeutics completes financing round for development of cell therapy products

Neukio Biotherapeutics, a Chinese company committed to developing novel cell therapy products, has closed $50 million in a series A-1 funding round. The investment round was led by CD Capital, with the participation of Alwin Capital and Surplus Capital as new investors. Existing shareholders Lilly Asia Ventures, Sherpa Healthcare Partners and IDG Capital have continued […]

September 2, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 2 Sep 2022

Manus Bio receives additional funding to fight malaria with biotech

U.S. biomanufacturer Manus Bio has received a fourth award from the Bill & Melinda Gates Foundation to develop a scalable production route for the potential antimalarial drug, artemisinin. The $2 million award will enable Manus Bio to begin scaling up the biological process it has developed towards the chemical intermediate, dihydroartemisinic acid. Economical and scalable […]

September 2, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 1 Sep 2022

Brainomix awarded tender to deploy AI stroke imaging across whole of Hungary

Artificial intelligence (AI) stroke imaging will be deployed across centers in Hungary after Brainomix was awarded a national tender. The company was granted the tender for all stroke centers in the country as part of the National Institute for Health Development initiative to improve stroke care. Following a competitive process, the five-year program that was […]

September 1, 2022 - 4 minutesmins - By Liza Laws

News and Trends 1 Sep 2022

Provention Bio looks to advance diabetes drug through $125M loan

U.S. biopharma company Provention Bio, Inc. has secured a term loan facility of up to $125 million with Hercules Capital, Inc. ahead of the company’s potential launch of teplizumab. The BLA for teplizumab, Provention Bio’s lead investigational drug candidate, for the delay of progression to stage 3 clinical type 1 diabetes in at-risk individuals has […]

September 1, 2022 - 2 minutesmins - By Jim Cornall

gastrointestinal disease heptares imperial2 1

News and Trends 30 Aug 2022

Bactolife receives $5M in new funding to address gut infections worldwide

Bactolife has received an investment of $5 million from The Bill & Melinda Gates Foundation to accelerate the use of its technology platform that develops binding proteins for gut infections. The news was announced today (August 30) that in line with the foundation’s charitable mission, the investment would help develop the binding proteins which the […]

August 30, 2022 - 2 minutesmins - By Liza Laws

News and Trends 26 Aug 2022

Aktis Oncology raises millions in funding bringing total to $161M

Aktis Oncology announced yesterday (August 25) that it has raised a series A extension financing of $84 million bringing its total capital raised to date to $161 million. The Massachusetts-based company develops targeted alpha radiopharmaceuticals to treat a broad range of solid tumors. Aktis Oncology‘s investors The extension included participation from new health investors Cowen […]

August 26, 2022 - 2 minutesmins - By Liza Laws

News and Trends 26 Aug 2022

Ordaōs raises $5M to accelerate drug design and discovery

U.S. biotech company Ordaōs has raised $5 million in seed financing to aid in new product development and expand partner acquisition efforts. The oversubscribed round was led by Middleland Capital’s VTC Ventures with additional investments from Route 66 Ventures, Banyan Pacific Capital, IAG Capital Partners, and Citta Capital. Ordaōs is a drug design company that […]

August 26, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 25 Aug 2022

3T Biosciences launches with $40M financing

3T Biosciences wants to change the future of treatment for solid tumors and other immune-mediated diseases. And it exited from stealth today backed by $40 million in series A financing led by Westlake Village BioPartners with participation from Lightspeed Venture Partners. Proceeds from the financing will be used to help accelerate 3T Biosciences from a […]

August 25, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 25 Aug 2022

Scottish researchers can tap into new £300K fund

Precision Medicine Scotland Innovation Centre (PMS-IC), the national center for accelerating the advancement and adoption of precision medicine, has launched a new fund to support Scottish researchers. The $300,000 ($355,000) fund, the first offered by PMS-IC, will support research ideas to support accurate diagnosis and/or treatment based on an individual’s unique biology. Funds of up […]

August 25, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 25 Aug 2022

Zelluna Immunotherapy announces investment from Takeda Ventures, Inc.

Zelluna Immunotherapy, a company focused on allogenic T-cell Receptor Natural Killer (TCR-NK) cells to treat cancer has today (August 25) announced an investment from Takeda Ventures, Inc. (TVI), the strategic arm of Takeda. TVI investment joins Zelluna’s latest financing round. The funds will enable the advancement of a lead TCR-NK product through manufacturing to Clinical […]

August 25, 2022 - 2 minutesmins - By Liza Laws

News and Trends 25 Aug 2022

KU Leuven spin-off AstriVax raises €30M for vaccine platform – first stop, yellow fever

A Belgian university spinoff has generated the biggest seed capital financing in the institution’s history. Closing with €30 million ($30 million), AstriVax will draw on technology developed at the KU Leuven Rega Institute to develop novel vaccines that are easy to produce, have reduced cold chain requirements, and offer broad and long-lasting protection against various […]

August 25, 2022 - 3 minutesmins - By Jim Cornall

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Funding

Abivax pulls in €49.2M but needs more to complete ulcerative colitis program

Neukio Biotherapeutics completes financing round for development of cell therapy products

Manus Bio receives additional funding to fight malaria with biotech

Brainomix awarded tender to deploy AI stroke imaging across whole of Hungary

Provention Bio looks to advance diabetes drug through $125M loan

Bactolife receives $5M in new funding to address gut infections worldwide

Aktis Oncology raises millions in funding bringing total to $161M

Ordaōs raises $5M to accelerate drug design and discovery

3T Biosciences launches with $40M financing

Scottish researchers can tap into new £300K fund

Zelluna Immunotherapy announces investment from Takeda Ventures, Inc.

KU Leuven spin-off AstriVax raises €30M for vaccine platform – first stop, yellow fever

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!